ATRC - AtriCure Inc logo

ATRC

AtriCure Inc

AtriCure develops, manufactures, and sells devices for surgical ablation of cardiac tissue and intercostal nerves. Its product portfolio includes systems for treating cardiac arrhythmias and pain management, serving medical centers globally.

โš•๏ธ Healthcare NASDAQ Listed 2005 $ USD
$1,000 invested 20 years ago โ†’$8,007today

Score Overview

1 Year
Score
Net Growth192.17%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth6.57%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.6
Net Growth-78.98%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth107.64%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth131.65%
Net Trend60%
Net Income Consistency
Rev Growth267.24%
Rev Trend90%
Revenue Consistency
20 Years
Score4.8
Net Growth176.92%
Net Trend45%
Net Income Consistency
Rev Growth14x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth183.20%
Net Trend43%
Net Income Consistency
Rev Growth18x
Rev Trend90%
Revenue Consistency

See the full market ranking โ†’

AtriCure Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 206M to $ 534M and net income went from -$ 48M to -$ 11M. Revenue increased in every one of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 129M to $ 534M and net income went from -$ 27M to -$ 11M. Revenue increased in 9 of those 10 years; net income in 6.

AtriCure Inc currently holds a 20-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 43.56โ€”
1 Year2025-08-12
$ 35.8421.54%
5 Years2021-08-12
$ 73.56-40.78%
10 Years2016-08-12
$ 15.48181.40%
20 Years2006-08-11
$ 5.448x
All Time2005-08-05
$ 14.08209.38%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 569M$ 10M$ 167M
2025$ 534M-$ 11M$ 167M
2024$ 465M-$ 44M$ 122M
2023$ 399M-$ 30M$ 137M
2022$ 330M-$ 46M$ 121M
2021$ 274M$ 50M$ 119M
2020$ 206M-$ 48M$ 244M
2019$ 230M-$ 35M$ 81M
2018$ 201M-$ 21M$ 124M
2017$ 174M-$ 26M$ 34M
2016$ 155M-$ 33M$ 44M
2015$ 129M-$ 27M$ 34M
2014$ 107M-$ 16M$ 59M
2013$ 81M-$ 11M$ 26M
2012$ 70M-$ 7M$ 12M
2011$ 64M-$ 5M$ 14M
2010$ 59M-$ 3M$ 12M
2009$ 54M-$ 16M$ 15M
2008$ 55M-$ 10M$ 11M
2007$ 48M-$ 11M$ 20M
2006$ 38M-$ 13M$ 19M
IPO2005$ 30M-$ 12M$ 33M

Explore beyond ATRC

You're looking at AtriCure Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies